The trial design draft is going to be absolutely critical; I would rather RAC take a little longer and nail it down properly, they need to show cardio protection without actual damage from Dox so dosages are super important, they need to get it right as safety is of utmost priority.
- Forums
- General
- General Comments / Chat
RAC
race oncology ltd
Add to My Watchlist
1.22%
!
$1.24

The trial design draft is going to be absolutely critical; I...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.24 |
Change
0.015(1.22%) |
Mkt cap ! $215.4M |
Open | High | Low | Value | Volume |
$1.26 | $1.26 | $1.23 | $106.2K | 85.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 11900 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 819 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11900 | 1.220 |
2 | 2823 | 1.215 |
2 | 5223 | 1.210 |
1 | 600 | 1.205 |
5 | 30774 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 819 | 1 |
1.260 | 10000 | 1 |
1.280 | 4060 | 1 |
1.300 | 9431 | 2 |
1.310 | 2360 | 1 |
Last trade - 15.56pm 26/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online